Table 5 Association between HIF-1a expression with time to recurrence by ER/TAM group among 1682 subjects from the ProBe CaRe population-based case control study
ER/TAM Group | Intercept (SE) | Effect estimate β (SE) | 95% CI |
|---|---|---|---|
ER+/TAM+ | 0.18 (0.50) | 0.005 (0.12) | (− 0.23, 0.24) |
ER−/TAM− | 0.95 (0.51) | − 0.27 (0.18) | (− 0.62, 0.08) |